Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines

Palifermin Reduces Severe Mucositis in Definitive Chemoradiotherapy of Locally Advanced Head and Neck Cancer: A Randomized, Placebo-Controlled Study

(2011) Quynh-Thu Le et al.   JOURNAL OF CLINICAL ONCOLOGY

A Deletion Polymorphism in Glutathione-S-Transferase Mu (GSTM1) and/or Theta (GSTT1) Is Associated with an Increased Risk of Toxicity after Autologous Blood and Marrow Transplantation

(2010) Theresa Hahn et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Incidence and risk factors for lower alimentary tract mucositis after 1529 courses of chemotherapy in a homogenous population of oncology patients

(2010) Somashekar G. Krishna et al.   CANCER

Mucositis and non-invasive markers of small intestinal function

(2010) Katie L. Tooley et al.   CANCER BIOLOGY & THERAPY

Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Recombinant Human Intestinal Trefoil Factor Oral Spray for Prevention of Oral Mucositis in Patients With Colorectal Cancer Who Are Receiving Fluorouracil-Based Chemotherapy

(2009) Douglas E. Peterson et al.   JOURNAL OF CLINICAL ONCOLOGY

Nutritional support for head and neck cancer patients receiving radiotherapy: a systematic review

(2009) Shashank Garg et al.   SUPPORTIVE CARE IN CANCER

The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents

(2009) Kamalesh Sankhala et al.   Targeted Oncology

Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy

(2008) Linda S. Elting et al.   CANCER

Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group

(2008) Matthias Schwab et al.   JOURNAL OF CLINICAL ONCOLOGY